Compare ALNT & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALNT | NNNN |
|---|---|---|
| Founded | 1962 | 2021 |
| Country | United States | Germany |
| Employees | N/A | 27 |
| Industry | Electrical Products | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 1995 | N/A |
| Metric | ALNT | NNNN |
|---|---|---|
| Price | $65.96 | $25.50 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $64.50 | N/A |
| AVG Volume (30 Days) | ★ 157.9K | 12.8K |
| Earning Date | 05-06-2026 | 04-07-2026 |
| Dividend Yield | ★ 0.16% | N/A |
| EPS Growth | ★ 67.09 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $554,478,000.00 | N/A |
| Revenue This Year | $7.53 | N/A |
| Revenue Next Year | $6.64 | N/A |
| P/E Ratio | ★ $206.75 | $446.57 |
| Revenue Growth | ★ 4.62 | N/A |
| 52 Week Low | $29.25 | $7.03 |
| 52 Week High | $80.39 | $55.65 |
| Indicator | ALNT | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 41.29 | 48.07 |
| Support Level | $57.71 | $26.31 |
| Resistance Level | $67.79 | $30.21 |
| Average True Range (ATR) | 3.65 | 2.10 |
| MACD | -1.04 | -0.30 |
| Stochastic Oscillator | 26.29 | 16.25 |
Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty controlled motion components and systems. The firm mainly caters to the Industrial, Vehicle, Aerospace & Defense, and Medical sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).